Literature DB >> 9770719

Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors.

C Wang1, M S Kurzer.   

Abstract

Phytoestrogen effects on estrogen action and tyrosine kinase activity have been proposed to contribute to cancer prevention. To study these mechanisms, a number of phytoestrogens and related compounds were evaluated for their effects on DNA synthesis (estimated by thymidine incorporation analysis) in estrogen-dependent MCF-7 cells in the presence of estradiol (E2), tamoxifen, insulin, or epidermal growth factor. We observed that 1) at 0.01-10 microM, genistein and coumestrol enhanced E2-induced DNA synthesis, as did 10 microM enterolactone. Chrysin at 1.0-10 microM and 10 microM luteolin or apigenin inhibited E2-induced DNA synthesis, as did all compounds at > 10 microM, 2) tamoxifen enhanced genistein-induced DNA synthesis but inhibited DNA synthesis induced by all other compounds, and 3) genistein enhanced insulin- and epidermal growth factor-induced DNA synthesis at 0.1-1.0 and 0.1-10 microM, respectively. At higher concentrations, inhibition was observed. Similar effects were seen with coumestrol. In conclusion, the effects of phytoestrogens in the presence of E2 or growth factors are concentration dependent and variable. At low concentrations, genistein and coumestrol significantly enhanced E2-induced and tyrosine kinase-mediated DNA synthesis; at high concentrations, inhibition was observed. Differing effects were observed with the other compounds. The variable effects of phytoestrogens on DNA synthesis must be considered when their roles in cancer prevention or treatment are evaluated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770719     DOI: 10.1080/01635589809514686

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  12 in total

Review 1.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

Review 2.  The Role of Secondary Metabolites on Gynecologic Cancer Therapy: Some Pathways and Mechanisms.

Authors:  Mürşide Ayşe Demirel; İpek Süntar
Journal:  Turk J Pharm Sci       Date:  2017-11-20

3.  The influence of hollyhock extract administration on testicular function in rats.

Authors:  Monika A Papiez
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

Review 4.  Apigenin: a promising molecule for cancer prevention.

Authors:  Sanjeev Shukla; Sanjay Gupta
Journal:  Pharm Res       Date:  2010-03-20       Impact factor: 4.200

5.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

Review 6.  Cannabis sativa: The Plant of the Thousand and One Molecules.

Authors:  Christelle M Andre; Jean-Francois Hausman; Gea Guerriero
Journal:  Front Plant Sci       Date:  2016-02-04       Impact factor: 5.753

7.  Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice.

Authors:  Z Lian; K Niwa; K Tagami; M Hashimoto; J Gao; Y Yokoyama; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  2001-07

8.  Anticancer activity evaluation of kuanoniamines A and C isolated from the marine sponge Oceanapia sagittaria, collected from the Gulf of Thailand.

Authors:  Anake Kijjoa; Rawiwan Wattanadilok; Nair Campos; Maria São José Nascimento; Madalena Pinto; Werner Herz
Journal:  Mar Drugs       Date:  2007-04-17       Impact factor: 5.118

9.  Coumestrol inhibits autoantibody production through modulating Th1 response in experimental autoimmune thyroiditis.

Authors:  Xiaojing Jin; Shujun Wang; Xuemin Zhao; Qian Jin; Chenling Fan; Jing Li; Zhongyan Shan; Weiping Teng
Journal:  Oncotarget       Date:  2016-08-16

Review 10.  Biphasic Dose-Response Induced by Phytochemicals: Experimental Evidence.

Authors:  Jadwiga Jodynis-Liebert; Małgorzata Kujawska
Journal:  J Clin Med       Date:  2020-03-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.